Annual Shareholders Equity
$336.68 M
+$121.07 M+56.15%
31 December 2023
Summary:
Protagonist Therapeutics annual stockholders equity is currently $336.68 million, with the most recent change of +$121.07 million (+56.15%) on 31 December 2023. During the last 3 years, it has risen by +$36.66 million (+12.22%). PTGX annual shareholders equity is now at all-time high.PTGX Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Shareholders Equity
$531.91 M
-$9.41 M-1.74%
30 September 2024
Summary:
Protagonist Therapeutics quarterly stockholders equity is currently $531.91 million, with the most recent change of -$9.41 million (-1.74%) on 30 September 2024. Over the past year, it has increased by +$195.24 million (+57.99%). PTGX quarterly shareholders equity is now -5.09% below its all-time high of $560.44 million, reached on 31 March 2024.PTGX Quarterly Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
PTGX Shareholders Equity Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | - | +58.0% |
| 3 y3 years | +12.2% | +77.3% |
| 5 y5 years | +321.0% | +565.2% |
PTGX Shareholders Equity High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | at high | +56.1% | -5.1% | +146.7% |
| 5 y | 5 years | at high | +321.0% | -5.1% | +748.8% |
| alltime | all time | at high | +4132.3% | -5.1% | +5443.1% |
Protagonist Therapeutics Shareholders Equity History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $531.91 M(-1.7%) |
| June 2024 | - | $541.32 M(-3.4%) |
| Mar 2024 | - | $560.44 M(+66.5%) |
| Dec 2023 | $336.68 M(+56.2%) | $336.68 M(+11.4%) |
| Sept 2023 | - | $302.15 M(+2.7%) |
| June 2023 | - | $294.07 M(+36.0%) |
| Mar 2023 | - | $216.17 M(+0.3%) |
| Dec 2022 | $215.61 M(-28.1%) | $215.61 M(-11.5%) |
| Sept 2022 | - | $243.62 M(-9.1%) |
| June 2022 | - | $267.98 M(-11.2%) |
| Mar 2022 | - | $301.78 M(+0.6%) |
| Dec 2021 | $300.02 M(+7.3%) | $300.02 M(-9.0%) |
| Sept 2021 | - | $329.66 M(-7.8%) |
| June 2021 | - | $357.45 M(+37.8%) |
| Mar 2021 | - | $259.33 M(-7.3%) |
| Dec 2020 | $279.61 M | $279.61 M(+64.9%) |
| Sept 2020 | - | $169.59 M(+1.3%) |
| June 2020 | - | $167.49 M(+167.3%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2020 | - | $62.67 M(-21.6%) |
| Dec 2019 | $79.96 M(-28.9%) | $79.96 M(-16.1%) |
| Sept 2019 | - | $95.36 M(+13.1%) |
| June 2019 | - | $84.32 M(-16.4%) |
| Mar 2019 | - | $100.83 M(-10.4%) |
| Dec 2018 | $112.52 M(-6.7%) | $112.52 M(-9.2%) |
| Sept 2018 | - | $123.96 M(+15.1%) |
| June 2018 | - | $107.66 M(-6.1%) |
| Mar 2018 | - | $114.62 M(-5.0%) |
| Dec 2017 | $120.63 M(+37.8%) | $120.63 M(+108.6%) |
| Sept 2017 | - | $57.84 M(-5.2%) |
| June 2017 | - | $61.03 M(-18.5%) |
| Mar 2017 | - | $74.89 M(-14.5%) |
| Dec 2016 | $87.56 M(+812.4%) | $87.56 M(-10.2%) |
| Sept 2016 | - | $97.49 M(+377.8%) |
| June 2016 | - | $20.41 M(-22.6%) |
| Mar 2016 | - | $26.38 M(+174.9%) |
| Dec 2015 | $9.60 M(+20.6%) | $9.60 M |
| Dec 2014 | $7.96 M | - |
FAQ
- What is Protagonist Therapeutics annual stockholders equity?
- What is the all time high annual shareholders equity for Protagonist Therapeutics?
- What is Protagonist Therapeutics quarterly stockholders equity?
- What is the all time high quarterly shareholders equity for Protagonist Therapeutics?
- What is Protagonist Therapeutics quarterly shareholders equity year-on-year change?
What is Protagonist Therapeutics annual stockholders equity?
The current annual shareholders equity of PTGX is $336.68 M
What is the all time high annual shareholders equity for Protagonist Therapeutics?
Protagonist Therapeutics all-time high annual stockholders equity is $336.68 M
What is Protagonist Therapeutics quarterly stockholders equity?
The current quarterly shareholders equity of PTGX is $531.91 M
What is the all time high quarterly shareholders equity for Protagonist Therapeutics?
Protagonist Therapeutics all-time high quarterly stockholders equity is $560.44 M
What is Protagonist Therapeutics quarterly shareholders equity year-on-year change?
Over the past year, PTGX quarterly stockholders equity has changed by +$195.24 M (+57.99%)